Mesenteric myofibroblastic tumor: NSAID therapy after incomplete resection

被引：15

作者：

Diop, B. ^{[1
]}

Konate, I. ^{[2
]}

Ka, S. ^{[1
]}

Sall, I. ^{[1
]}

Fall, D. ^{[1
]}

Dieng, M. ^{[2
]}

Wone, Y. ^{[1
]}

机构：

[1] Hop Mil Ouakam, Serv Chirurg, Dakar, Senegal

[2] CHU Aristide Le Dantec, Serv Chirurg Gen, Dakar, Senegal

来源：

JOURNAL OF VISCERAL SURGERY | 2011年 / 148卷 / 04期

关键词：

Myofibroblastic tumor; Inflammatory pseudotumor; Mesentery; Steroid; Non-steroidal anti-inflammatory drug; INFLAMMATORY PSEUDOTUMOR; CHILDREN; AGENT;

D O I：

10.1016/j.jviscsurg.2011.06.005

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Myofibroblastic tumors are inflammatory tumors that arise in viscera and soft tissue; their etiopathology is poorly understood. They are capable of infiltration of adjacent organs, local recurrence after surgical resection, and even of distant metastasis. These characteristics result in persistent debate as to the nature of these lesions - whether they are inflammatory or neoplastic, benign or malignant lesions? Diagnosis is almost always made based on histopathological findings. Traditional management is complete surgical excision, but this may be difficult or impossible when the lesion develops in proximity to vital structures. We report the case of a 59-year-old man who was treated in our institution for mesenteric myofibroblastic tumor. Complete resection was not possible due to local infiltration of the mesentery. Recurrence was noted 3 months after surgery; treatment with steroidal and then non-steroidal anti-inflammatory medications (NSAIDs) resulted in clinical and radiologic regression of the tumor. (C) 2011 Elsevier Masson SAS. All rights reserved.

引用

页码：E311 / E314

页数：4

共 16 条

[1] The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study [J].